Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3969302018 | Cytotoxic T-lymphocyte-associated protein 4 inhibitor | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3969303011 | Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 3969706017 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance) | Is a | Substance with immune checkpoint inhibitor mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier | ||
| Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance) | Has disposition | Cytotoxic T-lymphocyte-associated protein 4 inhibitor | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ipilimumab | Is a | True | Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR